Topics

South Korea's 5-year plan to advance clinical trials a boon for US biotech

12:32 EDT 13 Sep 2019 | Outsourcing-Pharma

South Korea looks to accelerate review timelines and study start-up with a new five-year plan that will benefit biotechs looking for locations outside the US to âramp upâ clinical development programs, says CRO.

Original Article: South Korea's 5-year plan to advance clinical trials a boon for US biotech

NEXT ARTICLE

More From BioPortfolio on "South Korea's 5-year plan to advance clinical trials a boon for US biotech"

Quick Search